Fubao Wang was Resigned as Senior Vice President and Head of Regulatory Affairs at Asklepios-BioPharmaceutical

Date of management change: May 15, 2022 

What Happened?

Research Triangle Park, -based Asklepios-BioPharmaceutical Resigned Fubao Wang as Senior Vice President and Head of Regulatory Affairs

 

About the Company

Asklepios BioPharmaceutical, Inc. (AskBio) is a leading clinical-stage adeno-associated virus (AAV) gene therapy company dedicated to improving the lives of patients with rare diseases and other genetic disorders.

 

About the Person

Fubao Wang is Senior Vice President and Head of Regulatory Affairs at Prime Medicine. Previously, Fubao held various senior legal leadership roles in the industry.

 

Info Source

News

 

imageShort Profile

 

Name: Fubao Wang

Title: Senior Vice President and Head of Regulatory Affairs

Company: Asklepios BioPharmaceutical

Industry: Biotechnology

imageCurrent Contact Info

 

Email: *****@primemedicine.com 

Phone:.***.***.*01* 

To get full contact details, please sign in or

 
Your email is safe with us: see our privacy policy
 

Other IT executives who recently changed jobs as well: McCarty Darren, Hudak-Roos Marty, Maddox Jerome, Wells James, Freeman Michael, Swartley Jason, McKnight Anne, Stabler Katherine, Stevens Jason, Sandusky Michael, Gafner Odette

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.